Analysis of spiritual well-being status and influencing factors in patients with esophageal cancer: a cross-sectional study
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08760-4 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Yiying Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Chengdu Medical College, Chengdu, 610500, Sichuan, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Spirituality. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Chengdu Medical College.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Chengdu Medical College, Chengdu, 610500, Sichuan, China.
- Sichuan Taikang Hospital, Chengdu, 610213, Sichuan, China.
- The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, Sichuan, China.
- School of Nursing, Chengdu Medical College, Chengdu, 610500, Sichuan, China. Limeizhangtg@163.com.
Förderung
- Chengdu Medical College
Zitieren
APA
Zhang, Y., Li, Y., Fang, T., Zhong, X., Yuan, P., Wang, M., Lu, W., Liu, J., & Zhang, L. (2024). Analysis of spiritual well-being status and influencing factors in patients with esophageal cancer: a cross-sectional study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08760-4
Vancouver
Zhang Y, Li Y, Fang T, Zhong X, Yuan P, Wang M, et al. Analysis of spiritual well-being status and influencing factors in patients with esophageal cancer: a cross-sectional study. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08760-4
BibTeX
@article{Zhang2024,
author = {Zhang, Yiying and Li, Yanjia and Fang, Ting and Zhong, Xiaoying and Yuan, Ping and Wang, Meng and Lu, Weinan and Liu, Jing and Zhang, Limei},
title = {Analysis of spiritual well-being status and influencing factors in patients with esophageal cancer: a cross-sectional study},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08760-4}
}
EUVIMED